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Introduction
Chlamydia genital infections are predominantly
sexually transmissible. Due to its high prevalence, its
course and possible complications, this disease has, up
to the present time, provoked a great interest of experts
from various fields of medicine. In lots of studies, the
significant place is, above all, occupied by the dia-
gnostic, preventive and therapeutic aspects of this
disease.
The infections caused by Chlamydia tracho-
matis (Ch. trachomatis) can result in female sterility
because of the development of salpingithis and ectopic
pregnancy. The genital Chlamydia infection in women
can become the risk factor for the development of the
Chlamydia infections of the eye and respiratory tract in
the newborn infants (1,2,3). There can be found very
controversial facts in the medical literature concerning
the effect of this bacterial infection on the fertility of
men, although it can be stated with great certainty that
Ch. trachomatis has the adherence effect upon
spermatozoids (4, 5, 6). The newest researches of Vigil
et. al. point out the findings of the reticular bodies in
the spermatozoids, which represents a very significant
fact for determining of the pathogenetic processes in
the Chlamydia infection in men (7) (Table 1).
The prevention of the development of such
serious and dangerous complications means timely
diagnosis and adequate therapy.
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The genital infections caused by Chlamydia trachomatis (Ch. trachomatis),
Mycoplasma hominis (M. hominis) and Ureaplasma urealyticum (U. urealyticum) represent,
in the countries with developed industry, those diseases which are most often sexually
transmissible. Chronic infections provoked by the mentioned causes are considered to be the
risk factors for sterility.
The aim of this paper is to examine the importance and specific characteristics of the
CHLAMYFAST-OIA test in the Chlamydia genital infection diagnosis. This study includes
400 male patients with urethritis symptoms. The CHLAMYFAST-optical immunologic test
has been used to determine the presence of the Ch. trachomatis in the genital tract of 360
males (Mycoplasma, International, France). The genital microplasmas, that is M. hominis and
U. urealyticum, have been detected with the use of MYCOFAST-test (Mycroplasm
International, France). The presence of the genital microplasmas has been studied in 129
patients.
Chlamydia genital infection has been determined in 128 males (35,55%). The genital
infection caused by M. hominis has been determined in a largely lower number of patients (3;
2,32%), as well as the infection caused by U. urealyticum (in 8 patients; 6,20%). Mixed
infections have been detected in 8 patients. In 6 men (4,64%) there has been detected a mixed
infection caused by genital microplasmas. The mixed infection provoked by Ch. trachomatis
and M. hominis, and the one caused by Ch. trachomatis and U. urealyticum, has been proven
only in one patient respectively. Acta Medica Medianae 2004; 43(3): 33-36.
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Infection Clinical entity Complications
Men urethritis,
epididimitis,
proctitis,
conjunctivitis
Ryter syndrome
Women cervicitis,
salpinghithis,
urethritis,
bartholinithis,
conjunctivitis  
ectopic pregnancy,
infertility,
arthritis, 
dermathitis
Newborn
infants
conjunctivitis intestinal pneumonia
Table 1. Possible complications of the
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Material and methods
This study includes 400 male patients with
urethritis symptoms. 
The material of the genital tract of men,
scarificat of the uretral mucosis, has been examined to
determine the presence of the Ch. trachomatis, as well
as of the genital microplasmas.
The CHLAYFAST-optical immunologic test
(Mycroplasma, International, France) has been used to
determine the presence of the Ch. trachomatis in the
genital tract of 360 men. There were 50 patients in the
age group who were younger than 30, 270 patients
were from 30 to 50 years old, and 40 patients were
older than 50. 
The genital microplasmas, that is Mycroplasma
hominis (M. hominis) and Ureaplasma urealyticum
(U. urealyticum) have been detected with the
MYCOFAST-test (Mycroplams, International, Fran-
ce). The presence of the genital microplasmas has
been studied in 129 patients.
There were 90 patients who underwent the
microbiological examination of the genital tract
material concerning the presence of both Ch.
trachomatis and genital microplasmas.
Results
The presence of the Chlamydia genital infection
has been determined in 128 men (35,55%). A
significantly lower percentage of patients have
suffered from the genital infection caused by both M.
hominis (3; 2,32%) and U. urealyticum (8; 6,20%)
(Table 2).
Mixed infections have been proved in 8
patients. In 6 men (4,64%) there has been determined
a mixed infection caused by genital microplasmas.
The mixed infection provoked by Ch. trachomatis and
M. hominis, as well as by Ch. trachomatis and  U.
urealyticum has been found in only one case
respectively.
Concerning the age structure of the patients no
significant difference has been recorded in the
findings of Ch. trachomatis. Namely, the highest
percentage of the Chlamydia genital infection has
been recorded in the patients who were from 30 to 50
years old (35,92%), whereas a somewhat lower
percentage has been determined in the patients
younger than 30 (32,00%) and those older than 50
(30,00%) ( Table 3).
Discussion and conclusion
The first recorded facts about the connection of
Ch. trachomatis and genital infections date as far as
from 1883, from Koch (8).
The turning point in diagnosing the Chlamydia
infections of the genital tract and eye was the
introduction of the immunofluorescence test by Wang
and Graystone, during the 70s, XX century. This
immunologic method created a possibility for the
satisfactory specificity and for the application of the
test in the routine diagnosing of the infections caused
by Ch. trachomatis (9, 10).
Up to 1970, there were successfully applied
methods of cultivating on the chicken embryo as well
as on the McCoy cells, but they, due to the technically
complicated and long procedure and economic factors,
represented more a part of the scientific research work
than of the routine operation (1,11).
The Chlamydia infections were, up to 1980,
mainly diagnosed by the process of proving the
presence of Ch. trachomatis in the epithelial cells of
the urethra, whether by cultivating the carrier or by
detecting of this kind using the direct immuno-
fluorescence methods (12). Numerous researches have
come up with the same results that the prevalence of
the Chlamydia infections exists in male patients
suffering from nonspecific urethritis, postgonococcal
urethritis, epididemitis as well as in female patients
suffering from salpingithis. American authors from
this period emphasize even the prevalence of the
Chlamydia infections in about 40% of patients with
the symptoms of urethritis (13). The researches done
in our country have almost identical results (4).
Taking into consideration the fact that, in cases
of the clinical form of epididemitis, prostatitis and
pelvic infection, the cause of the disease is not, in a
number of cases, in the urethra secretion, then there
emerged a need to perform the immunologic diagnosis
of the specific antibodies in the patient serum.
Immunologic examinations determined that the IgM
specific antibodies represented the indicator of the
acute Chlamydia infection in patients. The findings of
the specific IgG antibodies in the low titer still repre-
sent a disputable fact, although according to the opini-
on of most of the authors they may represent the per-
Age The total number
of checkups
Positive findings
of Ch. trachomatis
Under 30 50 19 (32,00%)
From 30 to 50 270 97 (35,92%)
Over 50 40 12 (30,00%)
Findings
Number of
the
examined
patients
Number of
the positive
patients
% of the
positive
patients
Ch. Trachomatis 360 128 35,55%
M. hominis 129 3 2,32
U. urealyticum 129 8 6,20
M.hominis+U.
urealyticum 129 6 4,64
Ch.trachomatis +
M.hominis 90 1 1,11
Ch.trachomatis +
U. urealyticum 90 1 1,11
Table 2. The findings of the Ch. trachomatis
and genital microplasmas
Table 3. The findings of Ch. trachomatis in patients of
different age sisting antibodies after the cured Chlamydia infection.
The findings of the specific IgA antibodies have, from
1984 and considering some authors, become the
marker of the active Chlamydia infection (4).
Technological development which made
possible the establishing of the methods of molecular
biology in the research analyses of the Chlamydia
infections of the human genital tract, also created a
possibility of determining the presence of Ch.
trachomatis when in small number. This made it
possible for the researches to detect the cause in
asymptomatic male patients as well as in those with
chronic infection. Introducing these methods in the
research analyses has recently had as a result the facts
that there does not exist a correlation between the
findings of the specific antibodies in the serum and the
presence of Ch. trachomatis in the serum, which was
confirmed by the use of the DNA tests (3). These latest
facts point out the necessity of introducing the
methods of molecular biology in the routine diagnosis
of Chlamydia infections in strictly chosen groups of
population (2,14).
It is a fact that the infection caused by Ch.
trachomatis may in a certain number of cases remain
nondiagnosed, whether because of the use of some less
sensitive methods, used in diagnosis, or because of the
minimal symptoms or because of the absence of the
infection signs in patients.
There exist a number of diagnostic methods that
used to be recommended for determining the presence
of  Ch. trachomatis in the male and female genital
tracts. In the routine practice, in order to diagnose the
Chlamydia infection there are most often used the
direct and indirect immunofluorescence (ITF) and
immunoenzyme (ELISA) tests. The reference books
have lately referred to these methods (ITF, ELISA and
cultivating methods) as to the methods of less
specificity and sensitivity, recommending at the same
time the tests for the detection of DNA causes (15,2).
Taking into consideration the latest studies,
there stand out, as the most specific tests, the methods
of molecular biology, that is, the methods of the chain
multiplying like the polymerase chain reaction (PCR)
and ligase chain reaction (LCR). Many authors have
emphasized that the sensitivity of the methods of chain
multiplying is 10 to 50% higher than that of the routine
methods, and that these methods represent the
methods of choice in asymptomatic infections, as well
as in the screening researches of the prevalence of the
Chlamydia infections (2).
The CHLAMIFAST-optic immunologic test has
been used in this paper for diagnosing the Chlamydia
genital infections in men. The optic immunologic test
is very simple to perform, technically it makes
possible the direct visual detection of the cause of the
disease, that is the detection of the extracted
lipopolysaccharid antigen characteristic for Ch. tra-
chomatis.
The sediment of the molecular thin layer with
the specific antibodies changes in the precipitory test,
which causes the change of the refracted light from the
test surface, that is the change of the color on the
surface so that the test can be easily read with the
naked eye.
This research has determined a very significant
prevalence of the genital Chlamydia infections in men
with the symptoms of urethritis. Using the CHLA-
MYFAST-OIA test there has been found a significant
percentage of the Chlamydia infections in patients,
which emphasizes the diagnostic importance of this
test in the diagnosis of this sexually transmissible
disease. Taking into consideration that this research
includes only those patients with the emerging
symptoms of the genital infection, no conclusions can
be reached as to the application of this test in the
detection of Ch. trachomatis in asymptomatic carriers.
As far as the age structure of the examined
patients is concerned there has been recorded no
significant difference in the percentage of men with
the genital Chlamydia infection. The important
prevalence of this infection has been proved in all
patients.
The fact that there was a small number of
patients with mixed infections, whether caused by
Chlamydia infections together with some other kind of
genital microplasmas or the ones caused by the M.
hominis and U. urealyticum, points out the possibility
of encountering certain problems in the process of
diagnosing and giving a proper therapy. Academically
speaking, each patient should indeed undergo a
complete microbiological and parasitological
examination of the genital tract. Yet, considering the
fact that the number of patients with mixed infections
is small, the academic approach would be, in any case,
economically improper, if we want to be practical.
Some further researches could establish the principles
that would be used in case one doubts the presence of
the mixed infection caused by Ch. trachomatis and
genital microplasmas.
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CHLAMYFAST-OIA TEST U DIJAGNOSTICI
GENITALNIH HLAMIDIJSKIH INFEKCIJA MU[KARACA
Anka Vasi}, Nata{a Miladinovi} Tasi}, Dragan Zdravkovi} i Suzana Tasi} 
Genitalne infekcije izazvane vrstama Chlamydia trachomatis (Ch.tracho-matis),
Mycoplasma hominis (M.hominis) i Ureaplasma urealyticum (U.urealy-ticim), u industrij-
skim, razvijenim zemljama predstavljaju naj~e{}e seksualno transmisivne bolesti. Hroni~ne
infekcije izazvane ovim uzro~nicima smatraju se i faktorom rizika za nastanak steriliteta. Cilj
rada je ispitati zna~aj i specifi~nost CHLAMYFAST-OIA testa u dijagnostici hlamidijskih
genitalnih infekcija.
U ovoj studiji obuhva}eno je 400 mu{karaca sa simptomima uretritisa. Za utvr|ivanje
prisustva vrste Ch. trachomatis u genitalnom traktu 360 mu{karaca kori{}en je CHLA-
MYFAST-opti~ki imunski test (Mycoplasma, International, France). Genitalne mikoplazme,
odnosno vrste  M. hominis i  U. urealyticum, detektovane su primenom  MYCOFAST- testa
(Mycoplasma International, France). 
Prisustvo genitalnih mikoplazmi ispitivano je kod 129 bolesnika. Hlamidijska geni-
talna infekcija utvr|ena je kod 128 mu{karaca (35,55%). U znatno ni`em procentu kod
bolesnika zabele`ena je genitalna infekcija izazvana vrstom M. hominis (3; 2,32%), kao i
vrstom U. urealyticum (8; 6,20%). Me{ane infekcije dokazane su kod 8 bolesnika. Kod 6
(4,64%) mu{karaca utvr|ena je me{ana infekcija genitalnim mikoplazmama. Samo u po
jednom slu~aju kod ispitivanih bolesnika zabele`ena je me{ana infekcija izazvana vrstama
Ch. trachomatis i M. hominis, kao i vrstama Ch. trachomatis i U. urealyticum. Acta Medica
Medianae 2004; 43(3): 33-36.
Klju~ne re~i: genitalne infekcije, Chlamydia trachomatis, Mycoplasma hominis,
Ureaplasma urealyticum